Cited by 37Alzheimer's disease research and treatmentsAmyotrophic Lateral Sclerosis ResearchNeuroinflammation and Neurodegeneration Mechanisms

A Conserved Cytoskeletal Signaling Cascade Mediates Neurotoxicity of FTDP-17 Tau Mutations In Vivo

Open access
Bardai, Farah H., Wang, Liqun, Mutreja, Yamini, Yenjerla, Mythili, Gamblin, T. Chris, Feany, Mel B.·2018·The Journal of Neuroscience

Abstract

The microtubule binding protein tau is strongly implicated in multiple neurodegenerative disorders, including frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17), which is caused by mutations in tau.In vitro, FTDP-17 mutant versions of tau can reduce microtubule binding and increase the aggregation of tau, but the mechanism by which these mutations promote disease in vivo is not clear. Here we take a combined biochemical and in vivo modeling approach to define functional properties of tau driving neurotoxicity in vivo. We express wild-type human tau and five FTDP-17 mutant forms of tau in Drosophila using a site-directed insertion strategy to ensure equivalent levels of expression. We then analyze multiple markers of neurodegeneration and neurotoxicity in transgenic animals, including analysis of both males and females. We find that FTDP-17 mutations act to enhance phosphorylation of tau and thus promote neurotoxicity in an in vivo setting. Further, we demonstrate that phosphorylation-dependent excess stabilization of the actin cytoskeleton is a key phosphorylation-dependent mediator of the toxicity of wild-type tau and of all the FTDP-17 mutants tested. Finally, we show that important downstream pathways, including autophagy and the unfolded protein response, are coregulated with neurotoxicity and actin cytoskeletal stabilization in brains of flies expressing wild-type human and various FTDP-17 tau mutants, supporting a conserved mechanism of neurotoxicity of wild-type tau and FTDP-17 mutant tau in disease pathogenesis. SIGNIFICANCE STATEMENT The microtubule protein tau aggregates and forms insoluble inclusion bodies known as neurofibrillary tangles in the brain tissue of patients with a variety of neurodegenerative disorders, including Alzheimer's disease. The tau protein is thus widely felt to play a key role in promoting neurodegeneration. However, precisely how tau becomes toxic is unclear. Here we capitalize on an “experiment of nature” in which rare missense mutations in tau cause familial neurodegeneration and neurofibrillary tangle formation. By comparing the biochemical activities of different tau mutations with their in vivo toxicity in a well controlled Drosophila model system, we find that all mutations tested increase phosphorylation of tau and trigger a cascade of neurotoxicity critically impinging on the integrity of the actin cytoskeleton.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/jneurosci.1550-17.2017

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 59

  1. Alonso Adel C, Mederlyova A, Novak M, Grundke-Iqbal I, Iqbal K (2004) Promotion of hyperphosphorylation by frontotemporal dementia tau mutations. J Biol Chem 279:34873-34881. CrossRef Medline · DOI
  2. Bateman JR, Lee AM, Wu CT (2006) Site-specific transformation of Dro- sophila via phiC31 integrase-mediated cassette exchange. Genetics 173: 769 -777. CrossRef Medline · DOI
  3. Bier E, Vaessin H, Shepherd S, Lee K, McCall K, Barbel S, Ackerman L, Carretto R, Uemura T, Grell E (1989) Searching for pattern and muta- tion in the Drosophila genome with a P-lacZ vector. Genes Dev 3:1273- 1287. CrossRef Medline · DOI
  4. Bischof J, Maeda RK, Hediger M, Karch F, Basler K (2007) An optimized transgenesis system for Drosophila using germ-line-specific phiC31 inte- grases. Proc Natl Acad Sci U S A 104:3312-3317. CrossRef Medline · DOI
  5. Bodea LG, Eckert A, Ittner LM, Piguet O, Go ¨tz J (2016) Tau physiology and pathomechanisms in frontotemporal lobar degeneration. J Neurochem 138:71-94. CrossRef Medline · DOI · Paper page
  6. Carlson SW, Branden M, Voss K, Sun Q, Rankin CA, Gamblin TC (2007) A complex mechanism for inducer mediated tau polymerization. Biochem- istry 46:8838 -8849. CrossRef Medline · DOI
  7. Colodner KJ, Feany MB (2010) Glial fibrillary tangles and JAK/STAT- mediated glial and neuronal cell death in a Drosophila model of glial tauopathy. J Neurosci 30:16102-16113. CrossRef Medline · DOI
  8. Combs B, Gamblin TC (2012) FTDP-17 tau mutations induce distinct ef- fects on aggregation and microtubule interactions. Biochemistry 51: 8597-8607. CrossRef Medline · DOI · Paper page
  9. Cruts M, Theuns J, Van Broeckhoven C (2012) Locus-specific mutation databases for neurodegenerative brain diseases. Hum Mutat 33:1340 - 1344. CrossRef Medline · DOI
  10. David DC, Layfield R, Serpell L, Narain Y, Goedert M, Spillantini MG (2002) Proteasomal degradation of tau protein. J Neurochem 83:176 -185. CrossRef Medline · DOI · Paper page
  11. DeTure M, Ko LW, Yen S, Nacharaju P, Easson C, Lewis J, van Slegtenhorst M, Hutton M, Yen SH (2000) Missense tau mutations identified in FTDP-17 have a small effect on tau-microtubule interactions. Brain Res 853:5-14. CrossRef Medline · DOI
  12. DeTure M, Ko, LW, Easson C, Yen S-H (2002) Tau assembly in inducible transfectants expressing wild-type or FTDP-17 tau. Am J Pathol 161: 1711-1722. CrossRef Medline · DOI
  13. Feany MB, Dickson DW (1996) Neurodegenerative disorders with exten- sive tau pathology: a comparative study and review. Ann Neurol 40:139 - 148. CrossRef Medline · DOI
  14. Foley KS, Young PW (2014) The non-muscle functions of actinins: an up- date. Biochem J 459:1-13. CrossRef Medline · DOI
  15. Frost B, Bardai FH, Feany MB (2016) Lamin dysfunction mediates neuro- degeneration in tauopathies. Curr Biol 26:129 -136. CrossRef Medline · DOI · Paper page
  16. Fulga TA, Elson-Schwab I, Khurana V, Steinhilb ML, Spires TL, Hyman BT, Feany MB (2007) Abnormal bundling and accumulation of F-actin me- diates tau-induced neuronal degeneration in vivo. Nat Cell Biol 9:139 - 148. CrossRef Medline · DOI · Paper page
  17. Gamblin TC, King ME, Dawson H, Vitek MP, Kuret J, Berry RW, Binder LI (2000) In vitro polymerization of tau protein monitored by laser light scattering: method and application to the study of FTDP-17 mutants. Biochemistry 39:6136 -6144. CrossRef Medline · DOI
  18. Gamblin TC, Berry RW, Binder LI (2003) Tau polymerization: role of the amino terminus. Biochemistry 42:2252-2257. CrossRef Medline · DOI
  19. Ghetti B, Oblak AL, Boeve BF, Johnson KA, Dickerson BC, Goedert M (2015) Invited review: frontotemporal dementia caused by microtubule- associated protein tau gene (MAPT) mutations: a chameleon for neuropa- thology and neuroimaging: MAPT mutations and FTD. Neuropathol Appl Neurobiol 41:24 -46. CrossRef Medline · DOI
  20. Hasegawa M, Smith MJ, Goedert M (1998) Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly. FEBS Lett 437:207-210. CrossRef Medline · DOI
  21. Hegde VR, Vogel R, Feany MB (2014) Glia are critical for the neuropathol- ogy of complex I deficiency in Drosophila. Hum Mol Genet 23:4686 - 4692. CrossRef Medline · DOI
  22. Hong M, Zhukareva V, Vogelsberg-Ragaglia V, Wszolek Z, Reed L, Miller BI, Geschwind DH, Bird TD, McKeel D, Goate A, Morris JC, Wilhelmsen KC, Schellenberg GD, Trojanowski JQ, Lee VM (1998) Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science 282:1914 -1917. CrossRef Medline · DOI
  23. Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, Pickering- Brown S, Chakraverty S, Isaacs A, Grover A, Hackett J, Adamson J, Lin- coln S, Dickson D, Davies P, Petersen RC, Stevens M, de Graaff E, Wauters E, van Baren J, et al (1998) Association of missense and 5Ј-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393:702- 705. CrossRef Medline · DOI · Paper page
  24. Jackson GR, Wiedau-Pazos M, Sang TK, Wagle N, Brown CA, Massachi S, Geschwind DH (2002) Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Dro- sophila. Neuron 34:509 -519. CrossRef Medline · DOI · Paper page
  25. Jeganathan S, von Bergen M, Brutlach H, Steinhoff, H.-J., and Mandelkow E (2006) Global hairpin folding of tau in solution. Biochemistry 45:2283- 2293. CrossRef Medline · DOI · Paper page
  26. Juha ´sz G, Hill JH, Yan Y, Sass M, Baehrecke EH, Backer JM, Neufeld TP (2008) The class III PI(3)K Vps34 promotes autophagy and endocytosis but not TOR signaling in Drosophila. J Cell Biol 181:655-666. CrossRef Medline · DOI
  27. Karpinar DP, Balija MBG, Ku ¨gler S, Opazo F, Rezaei-Ghaleh N, Wender N, Kim HY, Taschenberger G, Falkenburger BH, Heise H, Kumar A, Riedel D, Fichtner L, Voigt A, Braus GH, Giller K, Becker S, Herzig A, Baldus M, Ja ¨ckle H, et al (2009) Pre-fibrillar alpha-synuclein variants with im- paired beta-structure increase neurotoxicity in Parkinson's disease mod- els. EMBO J 28:3256 -3268. CrossRef Medline · DOI
  28. Lim J, Balastik M, Lee TH, Nakamura K, Liou YC, Sun A, Finn G, Pastorino L, Lee VM, Lu KP (2008) Pin1 has opposite effects on wild-type and P301L tau stability and tauopathy. J Clin Invest 118:1877-1889. CrossRef Medline · DOI
  29. Loewen CA, Feany MB (2010) The unfolded protein response protects from tau neurotoxicity in vivo. PloS One 5:e13084. CrossRef Medline · DOI
  30. Luheshi LM, Tartaglia GG, Brorsson AC, Pawar AP, Watson IE, Chiti F, Vendruscolo M, Lomas DA, Dobson CM, Crowther DC (2007) System- atic in vivo analysis of the intrinsic determinants of amyloid beta patho- genicity. PLoS Biol 5:e290. CrossRef Medline · DOI
  31. Mack TG, Dayanandan R, Van Slegtenhorst M, Whone A, Hutton M, Love- stone S, Anderton BH (2001) Tau proteins with frontotemporal dementia-17 mutations have both altered expression levels and phosphorylation pro- files in differentiated neuroblastoma cells. Neuroscience 108:701-712. CrossRef Medline · DOI
  32. Markstein M, Pitsouli C, Villalta C, Celniker SE, Perrimon N (2008) Ex- ploiting position effects and the gypsy retrovirus insulator to engineer precisely expressed transgenes. Nat Genet 40:476 -483. CrossRef Medline · DOI
  33. Martín-Blanco E, Gampel A, Ring J, Virdee K, Kirov N, Tolkovsky AM, Martinez-Arias A (1998) puckered encodes a phosphatase that mediates a feedback loop regulating JNK activity during dorsal closure in Drosoph- ila. Genes Dev 12:557-570. CrossRef Medline · DOI
  34. Martindale JL, Holbrook NJ (2002) Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol 192:1-15. CrossRef Medline · DOI
  35. Merlo P, Frost B, Peng S, Yang YJ, Park PJ, Feany M (2014) p53 prevents neurodegeneration by regulating synaptic genes. Proc Natl Acad Sci U S A 111:18055-18060. CrossRef Medline · DOI
  36. Miyasaka T, Morishima-Kawashima M, Ravid R, Heutink P, van Swieten JC, Nagashima K, Ihara Y (2001) Molecular analysis of mutant and wild- type tau deposited in the brain affected by the FTDP-17 R406W mutation. Am J Pathol 158:373-379. CrossRef Medline · DOI
  37. Mutreja Y, Gamblin TC (2017) Optimization of in vitro conditions to study the arachidonic acid induction of 4R isoforms of the microtubule- associated protein tau. In: Methods in cell biology (S.C. Feinstein, N.E. LaPointe, eds.), pp 65-88. Amsterdam: Elsevier.
  38. Nicholl DJ, Greenstone MA, Clarke CE, Rizzu P, Crooks D, Crowe A, Tro- janowski JQ, Lee VM, Heutink P (2003) An English kindred with a novel recessive tauopathy and respiratory failure. Ann Neurol 54:682-686. CrossRef Medline · DOI
  39. Osterwalder T, Yoon KS, White BH, Keshishian H (2001) A conditional tissue-specific transgene expression system using inducible GAL4. Proc Natl Acad Sci U S A 98:12596 -12601. CrossRef Medline · DOI
  40. Poorkaj P, Bird TD, Wijsman E, Nemens E, Garruto RM, Anderson L, An- dreadis A, Wiederholt WC, Raskind M, Schellenberg GD (1998) Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neu- rol 43:815-825. CrossRef Medline · DOI · Paper page
  41. Rankin CA, Sun Q, Gamblin TC (2005) Pseudo-phosphorylation of tau at Ser202 and Thr205 affects tau filament formation. Brain Res Mol Brain Res 138:84 -93. CrossRef Medline · DOI · Paper page
  42. Reed LA, Grabowski TJ, Schmidt ML, Morris JC, Goate A, Solodkin A, Van Hoesen GW, Schelper RL, Talbot CJ, Wragg MA, Trojanowski JQ (1997) Autosomal dominant dementia with widespread neurofibrillary tangles. Ann Neurol 42:564 -572. CrossRef Medline · DOI
  43. Reed LA, Wszolek ZK, Hutton M (2001) Phenotypic correlations in FTDP- 17. Neurobiol Aging 22:89 -107. CrossRef Medline · DOI
  44. Rohrer JD, Guerreiro R, Vandrovcova J, Uphill J, Reiman D, Beck J, Isaacs AM, Authier A, Ferrari R, Fox NC, Mackenzie IR, Warren JD, de Silva R, Holton J, Revesz T, Hardy J, Mead S, Rossor MN (2009) The heritability and genetics of frontotemporal lobar degeneration. Neurology 73:1451- 1456. CrossRef Medline · DOI · Paper page
  45. Rohrer JD, Ridgway GR, Modat M, Ourselin S, Mead S, Fox NC, Rossor MN, Warren JD (2010) Distinct profiles of brain atrophy in frontotemporal lobar degeneration caused by progranulin and tau mutations. Neuroim- age 53:1070 -1076. CrossRef Medline · DOI
  46. Rosso SM, van Herpen E, Deelen W, Kamphorst W, Severijnen LA, Willem- sen R, Ravid R, Niermeijer MF, Dooijes D, Smith MJ, Goedert M, Heutink P, van Swieten JC (2002) A novel tau mutation, S320F, causes a tauopa- thy with inclusions similar to those in Pick's disease. Ann Neurol 51:373- 376. CrossRef Medline · DOI
  47. Rosso SM, Donker Kaat L, Baks T, Joosse M, de Koning I, Pijnenburg Y, de Jong D, Dooijes D, Kamphorst W, Ravid R, Niermeijer MF, Verheij F, Kremer HP, Scheltens P, van Duijn CM, Heutink P, van Swieten JC (2003) Frontotemporal dementia in The Netherlands: patient character- istics and prevalence estimates from a population-based study. Brain 126: 2016 -2022. CrossRef Medline · DOI
  48. Ryoo HD, Domingos PM, Kang MJ, Steller H (2007) Unfolded protein re- sponse in a Drosophila model for retinal degeneration. EMBO J 26:242- 252. CrossRef Medline · DOI
  49. Santacruz K, Lewis J, Spires T, Paulson J, Kotilinek L, Ingelsson M, Guimaraes A, DeTure M, Ramsden M, McGowan E, Forster C, Yue M, Orne J, Janus C, Mariash A, Kuskowski M, Hyman B, Hutton M, Ashe KH (2005) Tau suppression in a neurodegenerative mouse model improves memory function. Science 309:476 -481. CrossRef Medline · DOI · Paper page
  50. Steinhilb ML, Dias-Santagata D, Mulkearns EE, Shulman JM, Biernat J, Man- delkow EM, Feany MB (2007b) S/P and T/P phosphorylation is critical for tau neurotoxicity in Drosophila. J Neurosci Res 85:1271-1278. CrossRef Medline · DOI · Paper page
  51. Szendrei GI, Lee VM, Otvos L Jr (1993) Recognition of the minimal epitope of monoclonal antibody Tau-1 depends upon the presence of a phosphate group but not its location. J Neurosci Res 34:243-249. CrossRef Medline · DOI
  52. Voss K, Combs B, Patterson KR, Binder LI, Gamblin TC (2012) Hsp70 alters tau function and aggregation in an isoform specific manner. Biochemistry 51:888 -898. CrossRef · DOI
  53. Wang L, Hagemann TL, Kalwa H, Michel T, Messing A, Feany MB (2015) Nitric oxide mediates glial-induced neurodegeneration in Alexander dis- ease. Nat Commun 6:8966. CrossRef Medline · DOI
  54. Wang L, Hagemann TL, Messing A, Feany MB (2016) An in vivo pharma- cological screen identifies cholinergic signaling as a therapeutic target in glial-based nervous system disease. J Neurosci 36:1445-1455. CrossRef Medline · DOI
  55. Williams DW, Kondo S, Krzyzanowska A, Hiromi Y, Truman JW (2006) Local caspase activity directs engulfment of dendrites during pruning. Nat Neurosci 9:1234 -1236. CrossRef Medline · DOI · Paper page
  56. Wittmann CW, Wszolek MF, Shulman JM, Salvaterra PM, Lewis J, Hutton M, Feany MB (2001) Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Science 293:711-714. CrossRef Medline · DOI · Paper page
  57. Yamada K, Patel TK, Hochgra ¨fe K, Mahan TE, Jiang H, Stewart FR, Man- delkow EM, Holtzman DM (2015) Analysis of in vivo turnover of tau in a mouse model of tauopathy. Mol Neurodegener 10:55. CrossRef Medline · DOI
  58. Zhou L, McInnes J, Wierda K, Holt M, Herrmann AG, Jackson RJ, Wang Y-C, Swerts J, Beyens J, Miskiewicz K, Vilain S, Dewachter I, Moechars D, De Strooper B, Spires-Jones TL, De Wit J, Verstreken P (2017) Tau associ- ation with synaptic vesicles causes presynaptic dysfunction. Nat Commun 8:15295. CrossRef Medline · DOI · Paper page
  59. Zhu X, Raina AK, Lee HG, Chao M, Nunomura A, Tabaton M, Petersen RB, Perry G, Smith MA (2003) Oxidative stress and neuronal adaptation in Alzheimer disease: the role of SAPK pathways. Antioxid Redox Signal 5:571-576. CrossRef Medline · DOI

Cited by

Sorted by citations

Authors
Bardai, F. H., Wang, L., Mutreja, Y., Yenjerla, M., Gamblin, T. C., & Feany, M. B.
Affiliations
  • Brigham and Women's Hospital (US)
  • University of Kansas (US)
Venue
The Journal of Neuroscience
Published
2017-11-14
Volume
38
Issue
1
Pages
108-119
ISSN
  • 0270-6474 (ISSN-L)
  • 1529-2401
OpenAlex
W2768415339
Cited by
37
References
9
Citations by year
2026: 1 · 2025: 1 · 2024: 2 · 2023: 4 · 2022: 4 · 2021: 4 · 2020: 10 · 2019: 5 · 2018: 6
FWCI
4.25
Type
journal article
Language
en
Open access
Locations
  • Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • KU ScholarWorks (University of Kansas) (acceptedVersion, cc-by)
Funders
  • National Institutes of Health
  • National Institute of Neurological Disorders and Stroke (R01NS083391)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD090255)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
tau protein, FTDP-17, tau mutations, neurotoxicity, tau phosphorylation, neurofibrillary tangles, autophagy, unfolded protein response, Drosophila model, neurodegeneration, microtubule binding, sex differences
MeSH terms
Actins, Animals, Autophagy, Cytoskeleton, Drosophila, Humans, Mutation, Phosphorylation, Signal Transduction, Mutagenesis, Insertional, tau Proteins, Conserved Sequence, Tauopathies, Animals, Genetically Modified, Unfolded Protein Response

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review